tiprankstipranks
Trending News
More News >
Hookipa Pharma Inc (HOOK)
OTHER OTC:HOOK
US Market

Hookipa Pharma (HOOK) Stock Forecast & Price Target

Compare
543 Followers
See the Price Targets and Ratings of:

HOOK Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Hookipa
Pharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HOOK Stock 12 Month Forecast

There Are No Analyst Ratings for HOOK In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

HOOK Financial Forecast

HOOK Earnings Forecast

Next quarter’s earnings estimate for HOOK is -$0.61 with a range of -$0.61 to -$0.61. The previous quarter’s EPS was -$1.23. HOOK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year HOOK has its overall industry.
Next quarter’s earnings estimate for HOOK is -$0.61 with a range of -$0.61 to -$0.61. The previous quarter’s EPS was -$1.23. HOOK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year HOOK has its overall industry.

HOOK Sales Forecast

Next quarter’s sales forecast for HOOK is $3.38M with a range of $3.38M to $3.38M. The previous quarter’s sales results were $2.00M. HOOK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year HOOK has its overall industry.
Next quarter’s sales forecast for HOOK is $3.38M with a range of $3.38M to $3.38M. The previous quarter’s sales results were $2.00M. HOOK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year HOOK has its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on HOOK
RBC Capital
RBC Capital
$2
Hold
124.72%
Upside
Reiterated
05/15/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Immunome (NASDAQ: IMNM), Oncolytics Biotech (NASDAQ: ONCY) and Hookipa Pharma (NASDAQ: HOOK)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on HOOK
RBC Capital
RBC Capital
$2
Hold
124.72%
Upside
Reiterated
05/15/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Immunome (NASDAQ: IMNM), Oncolytics Biotech (NASDAQ: ONCY) and Hookipa Pharma (NASDAQ: HOOK)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Hookipa Pharma

3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+23.60%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +23.60% per trade.
1 Year
OpenAI BiotechnologyTipRanks - OpenAI
Success Rate
1/1 ratings generated profit
100%
Average Return
+20.30%
reiterated a sell rating 5 months ago
Copying OpenAI Biotechnology's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +20.30% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+20.30%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +20.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HOOK Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Sep 25
Oct 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
7
6
5
3
4
Sell
6
3
7
4
4
Strong Sell
0
0
0
0
0
total
13
9
12
7
8
In the current month, HOOK has received 0 Buy Ratings, 4 Hold Ratings, and 4 Sell Ratings. HOOK average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

HOOK Stock Forecast FAQ

What is HOOK’s average 12-month price target, according to analysts?
Currently, no data Available
What is HOOK’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HOOK, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is HOOK a Buy, Sell or Hold?
      Currently, no data Available
      What is Hookipa Pharma Inc’s price target?
      Currently, no data Available
      What do analysts say about Hookipa Pharma Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of HOOK?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.